Pharmaceutical Robots Market Analysis Report By Product, By Application, By End-use, By Region And Segment Forecasts From 2021 To 2028

Synopsis

The global pharmaceutical robots market was prized by USD 142.9 million in 2020. It is estimated to witness 9.3% CAGR from 2021 to 2028.

Drivers

The increasing requirement for the mechanization in manufacturing divisions, in addition to the elevated expenses of finding the fresh medicine, is considerably raising the need for the robotics in laboratories, clinical trials, and medicine invention, which is intended for the mechanizing the actions.

Besides, the major companies are presenting technically superior robotic equipments; this has additionally initiated the remarkable expansion of the market for pharmaceutical robots. Then again, the Covid-19 pandemic is more powering the acceptance of pharmaceutical robots to augment internal production, reduce manufacturing expenses, and conquer scarcity of the manual labor, by way of mechanization, rather than contracting out, to diminish threats of international supply chain after Covid-19.

In spite of the excessive original investment, required for the setting up, the continuing benefits of robots have prepared them a gainful mechanism in manufacturing procedure, causing a superior return on investment. This machinery is three to four times quicker than human being and is able to work for 24 hours.

By means of the increasing contest in the pharmaceutical business, medicinal manufacturing companies are transforming production procedure by way of robotic equipment. This technology has made possible the augmented production capability with an increasing capacity to present superiority products on lesser expenses. These abovementioned reasons are projected to increase the requirement for pharmaceutical robots, designed for the production procedures, in the near future.

Effect of Covid-19

The current Covid-19 pandemic has considerably amplified the alertness about the benefits of mechanization in the pharma segment, intended for rising as well as continuing manufacture with no compromising security or excellence. Sequentially, this is helping the enlargement of the market for pharmaceutical robots.

COVID19 pharmaceutical robots market impact: 3.2% decrease in revenue

Application Insight

Picking and packaging section held the major, 53.9% share of the pharmaceutical robots market, in 2020. It is expected to observe the highest expansion, throughout the forecast period. Robots make possible high-pitched accuracy in addition to good organization, over and above assists in administering the challenges of material handling.

Pick and place permit management of floor area, because of the necessity for restricted work covering, thus making possible the most advantageous use of the workplace. The pharmaceutical robots, utilized in laboratories assist in enhancing the effectiveness plus the excellence of the products, by way of greater throughput study. Therefore, this section is projected to observe substantial augmentation, during the near future.

Product Insight

The traditional robots section held the principal, 64.1% share of the pharmaceutical robot market, in 2020. The section is more subdivided into dual-arm, delta/parallel, articulated, Cartesian, and SCARA robots.

The related benefits of the implementation of these products in a variety of industrialized mechanization functions, such as the material handling actions like place and pick, palletizing, unloading, de palletizing, loading, product position, sorting, cutting, stacking, scribing, plus others are certainly adding to the expansion of the section.

The collaborative robots section is expected to observe the highest augmentation, throughout the forecast period. In contrast to the traditional robots, these equipments are reasonably priced and simpler to maintain and operate. Moreover, they are light in weight and needs bare minimum expertise to deal with. Sequentially, this is transforming manufacturing divisions.

End Use Insight

In 2020, the pharmaceutical companies division held the leading, 66.9% share of the market. The division is anticipated to observe the highest expansion, during the forecast period. The pharmaceutical companies permit robot supported actions. It comprises internal laboratory functions, examination of the medicines along with packaging and picking. Besides, the rising use of robotics in pharmaceutical manufacturing is helping reproducibility and repeatability, at the same time dropping human mistakes.

On account of the rising use of robots in these amenities, the acceptance of pharmaceutical robots is additionally increasing between research laboratories. The mechanization of the laboratory has altered the R&D segment, in addition to made possible the fast examination of the test.

Moreover, the benefits presented by robots in laboratory functions, for example traceability, greater constancy, product reliability and better record-keeping, a growth in demand for well-organized workflow administration in research laboratories, plus the increase in the figure of plans being taken on by public and private companies to encourage mechanization are between the input factors, increasing the acceptance of pharmaceutical robots resolutions, thus helping the expansion of the market.

Regional Insight

In 2020, Asia Pacific held the major, 41.9% share of the global pharmaceutical robots market and is expected to observe the highest enlargement, throughout the forecast period. This is credited to the existence of a huge number of native pharmaceutical companies, within the nations like Japan. Besides, consistent with the International Federation of Robotics (IFR), China was the major market for industrial robots, in 2019. In line with a piece of writing by Robotics & Automation, published in October 2020, China held 140,500 units which was the biggest global share of industrial robot induction. Essentially, this was the effect of a substantial growth in sales in China. Therefore, main pharmaceutical companies, having huge manufacturing divisions in these nations, are likely to boost the expansion of this local market.

The enlargement of the market in North America can be credited to a big number of robot inductions, within the region. In accordance with the IFR, in the U.S., the trade of 33,000 industrial robots had taken place, in 2017.

Therefore, North America has a considerably greater infiltration of pharmaceutical robots. As a result of a growth in the figure of pharmaceutical companies within the nation, this figure is likely to increase during the near future.

The IFR furthermore confirmed that North America is involved in increasing its pharmaceutical manufacturing divisions to contest with the international market, by means of the mechanization of its manufacturing amenities.

Companies

The manufacturing companies have implemented the diverse policies, intended for achieving the reasonable advantage in the market such as, discrimination of the product, rising funds for R&D activities, geographical growth, and partnerships with new companies.

Some of the companies for pharmaceutical robots market are:

• Seiko Epson Corporation
• FANUC America Corporation
• Kawasaki Heavy Industries Ltd.
• ABB Ltd.
• Denso Wave, Inc.
• Marchesini Group S.p.A
• Yaskawa Electric Corporation
• Universal Robots A/S

Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2014 to 2028. For the purpose of this study, Million Insights, Inc. has segmented the global pharmaceutical robots market report on the basis of product, application, end-use, and region:

• Product Outlook (Revenue, USD Million, 2014 - 2028)
    • Traditional Robots
        • Articulated Robots
       • SCARA Robots
       • Delta/Parallel Robots
       • Cartesian Robots
       • Dual-arm Robots
    • Collaborative Pharmaceutical Robots

• Application Outlook (Revenue, USD Million, 2014 - 2028)
    • Picking and Packaging
    • Inspection of Pharmaceutical Drugs
    • Laboratory Applications

• End-use Outlook (Revenue, USD Million, 2014 - 2028)
    • Pharmaceutical Companies
    • Research Laboratories

• Regional Outlook (Revenue, USD Million, 2014 - 2028)
    • North America
       • U.S.
       • Canada
    • Europe
       • Germany
       • U.K.
    • Asia Pacific
       • Japan
       • China
       • India
    • Latin America
       • Brazil
       • Mexico
    • Middle East & Africa
       • South Africa